An attractive mechanistic target to investigate conditions of immune dysfunction is the mechanistic/mammalian target of rapamycin (mTOR), which has been directly linked with immune dysfunction and pulmonary damage after injury [35,36,37]. Here, MTOR is linked to immune system disorder.